Novo Holdings announced its investment in Manipal Hospitals (‘Manipal’), which constitutes Novo Holding’s largest investment in Asia to date. Manipal Hospitals is among the top healthcare providers in India, providing comprehensive curative and preventive care for a multitude of patients within India and from around the globe. Established in 1991 with the launch of its flagship hospital in Bangalore, Manipal has become one…
Novo Holdings A/S, an international investor in healthcare and life sciences, has announced that it has participated in the US$65.7 million Series C financing in Doctor Anywhere, a regional tech-led healthcare company headquartered in Singapore. As a result of the financing, Dr Amit Kakar, Senior Partner, Head of Novo Holdings Equity Asia will join the…
Novo Holdings announced that it has led the oversubscribed US$125 million Series C financing in Hummingbird Bioscience (Hummingbird), an innovative clinical-stage biotech company focused on developing precision therapies against difficult-to-drug targets to improve treatment outcomes. This is one of the first investments in a privately-held Asian biotech company by Novo Holdings. Novo Holdings recently established…